Goldman Sachs’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-18
| Closed | -$2.51K | – | 5228 |
|
|
2022
Q4 | $2.51K | Sell |
18
-21
| -54% | -$2.92K | ﹤0.01% | 5051 |
|
|
2022
Q3 | $20K | Buy |
39
+3
| +8% | +$1.54K | ﹤0.01% | 5169 |
|
|
2022
Q2 | $32K | Sell |
36
-1
| -3% | -$889 | ﹤0.01% | 5363 |
|
|
2022
Q1 | $93K | Sell |
37
-7
| -16% | -$17.6K | ﹤0.01% | 5333 |
|
|
2021
Q4 | $114K | Sell |
44
-32
| -42% | -$82.9K | ﹤0.01% | 5186 |
|
|
2021
Q3 | $350K | Buy |
76
+20
| +36% | +$92.1K | ﹤0.01% | 4577 |
|
|
2021
Q2 | $385K | Sell |
56
-3
| -5% | -$20.6K | ﹤0.01% | 4564 |
|
|
2021
Q1 | $428K | Sell |
59
-59
| -50% | -$428K | ﹤0.01% | 4459 |
|
|
2020
Q4 | $950K | Sell |
118
-5
| -4% | -$40.3K | ﹤0.01% | 3479 |
|
|
2020
Q3 | $1.26M | Buy |
123
+71
| +137% | +$728K | ﹤0.01% | 3177 |
|
|
2020
Q2 | $346K | Buy |
52
+34
| +189% | +$226K | ﹤0.01% | 3763 |
|
|
2020
Q1 | $82K | Buy |
+18
| New | +$82K | ﹤0.01% | 4200 |
|
|
2015
Q2 | – | Sell |
-29
| Closed | -$422K | – | 4719 |
|
|
2015
Q1 | $422K | Hold |
29
| – | – | ﹤0.01% | 3426 |
|
|
2014
Q4 | $387K | Hold |
29
| – | – | ﹤0.01% | 3522 |
|
|
2014
Q3 | $382K | Hold |
29
| – | – | ﹤0.01% | 3497 |
|
|
2014
Q2 | $507K | Hold |
29
| – | – | ﹤0.01% | 3343 |
|
|
2014
Q1 | $409K | Hold |
29
| – | – | ﹤0.01% | 3490 |
|
|
2013
Q4 | $342K | Hold |
29
| – | – | ﹤0.01% | 3632 |
|
|
2013
Q3 | $311K | Hold |
29
| – | – | ﹤0.01% | 3597 |
|
|
2013
Q2 | $278K | Buy |
+29
| New | +$278K | ﹤0.01% | 3470 |
|